Clinical Trials Directory

Trials / Completed

CompletedNCT04341792

Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient

Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic

Status
Completed
Phase
Study type
Observational
Enrollment
373 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is no predictive tool for patients admitted to the emergency department with a suspicion of Covid-19 that will worsen secondarily and require a heavy lifting. In a context of saturation of the healthcare system by the pandemic at Covid-19,it is essential to identify specific, accessible prognostic markers via minimally invasive sampling with low risk of infection for personnel caregiver, for optimal allocation of resuscitation resources. This study proposes to evaluate the biological markers of routine care known to be associated with resuscitation admission in relation to hospitalization on conventional service for the prediction of worsening of patients admitted to the emergencies for Covid-19.

Conditions

Timeline

Start date
2020-04-11
Primary completion
2020-11-12
Completion
2020-11-12
First posted
2020-04-10
Last updated
2025-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04341792. Inclusion in this directory is not an endorsement.

Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient (NCT04341792) · Clinical Trials Directory